September 18, 2014 – The use of generic medicines saved US patients and payors a total of USD 239 billion in 2013 – an increase of 14% over 2012 and more than in any previous year.

That was the main finding of a new study by the IMS Institute for Healthcare Informatics, commissioned by the US Generic Pharmaceutical Association (GPhA).

The latest study, details of which have just been released by GPhA, showed that the use of generics in the US saved a total of …